Overexpression of SLAMF1/CD150 or SLAMF7/CD319 in IGHV mutated CLL cell models resulted in reduced proliferation and impaired responses to BCR ligation, whereas the knockout of both receptors showed opposing effects and increased sensitivity toward inhibition of components of the BCR pathway. This evidence concerns the gene SLAMF1 and B-cell chronic lymphocytic leukemia.